Perimeter Medical’s Strong Q1 Surge in Clinical Trials
Company Announcements

Perimeter Medical’s Strong Q1 Surge in Clinical Trials

Perimeter Medical Imaging Ai Inc (TSE:PINK) has released an update.

Perimeter Medical Imaging AI, Inc. reported robust first quarter 2024 financial results, revealing a surge in patient enrollment for its pivotal clinical trial of AI-enhanced OCT technology for breast-conserving surgeries. The company’s commercial expansion is on a strong trajectory with three new S-Series OCT systems placed in hospitals, highlighting growing market acceptance and peer recommendations. Significant research findings support the need for innovative margin visualization technology like Perimeter’s to potentially reduce high reoperation rates in breast surgery.

For further insights into TSE:PINK stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskPerimeter Medical Imaging Completes Funding Round
TipRanks Canadian Auto-Generated NewsdeskPerimeter Medical Advances Breast Surgery AI Trial
TipRanks Canadian Auto-Generated NewsdeskPerimeter Medical Imaging AI Secures Over $9.8 Million Funding
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App